Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer/site build revision was updated from “v3.5.2” to “v3.5.3,” reflecting a backend or interface version change rather than an update to the trial record itself.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check56 days agoChange DetectedThe Record History gained new entries for Contacts/Locations and Study Status, with revision v3.5.0 released on 2026-03-18. The 2025-11-21 entry and revision v3.4.3 were removed.SummaryDifference0.6%

- Check63 days agoChange DetectedA new revision entry, v3.4.3, was added. The previous revision, v3.4.2, was removed.SummaryDifference0.1%

- Check92 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and the government funding lapse notice along with the prior revision entry (v3.4.1) were removed from the visible history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check99 days agoChange DetectedThe page history shows a new system notice about government funding and a new revision tag (v3.4.1) replacing the previous revision (v3.4.0).SummaryDifference0.8%

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.